Active surveillance (AS) is recommended as a management option for men with favorable-risk (low risk and favorable intermediate risk) prostate cancer; however, national rates remain low. The Michigan Urological Surgery Improvement Collaborative (MUSIC) established a quality improvement (QI) initiative in June 2014 to increase AS utilization. In this report, we analyze the rates of AS utilization over time in the state of Michigan (MUSIC) for men with favorable-risk prostate cancer and compare these to rates for other men diagnosed with favorable-risk prostate cancer in the USA outside the state of Michigan. While the variables that influence AS utilization were the same in both cohorts, we found that the AS utilization rates and the rate of increase were significantly higher in MUSIC. We conclude that the QI initiative started in MUSIC should serve as a roadmap to increasing AS use nationwide. PATIENT SUMMARY: Active surveillance (AS), which involves close monitoring with blood tests and scans, is recommended for management of favorable-risk prostate cancer to avoid or delay unnecessary treatment. Our results show that a quality improvement program in Michigan increased AS use for prostate cancer patients in the state. This program should be used to increase AS uptake throughout the USA.
European urology. 2022 Jun 07 [Epub ahead of print]
Randy A Vince, Yilun Sun, Brandon Mahal, Kevin Ginsburg, Arvin George, Michael Cher, Brian Lane, Richard Sarle, Todd M Morgan, Daniel E Spratt
Department of Urology, University of Michigan, Ann Arbor, MI, USA. Electronic address: ., Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Department of Radiation Oncology, University of Miami Sylvester Cancer Center, Miami, FL, USA., Department of Urology, Fox Chase Cancer Center, Philadelphia, PA, USA., Department of Urology, University of Michigan, Ann Arbor, MI, USA., Department of Urology, Wayne State University, Detroit, MI, USA., Division of Urology, Spectrum Health, Grand Rapids, MI, USA., Department of Urology, Sparrow Point Hospitals, Lansing, MI, USA., Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.